세계의 B2B 항곰팡이제 시장(2025년)

Global B2B Mold Inhibitors market size in terms of revenue is projected to reach 239.83 million USD by 2031 from 156.93 million USD in 2024, with a CAGR 5.20% during 2025-2031. Global B2B Mold Inhibitors market size in terms of sales is projected to reach 11,820 Tons by 2031 from 7,753 Tons in 2024, with a CAGR 5.84% during 2025-2031.

North America market for B2B Mold Inhibitors is estimated to increase from 44.28 million USD in 2024 to reach 58.65 million USD by 2031, at a CAGR of 4.04% during the forecast period of 2025 through 2031.

Europe market for B2B Mold Inhibitors is estimated to increase from 40.03 million USD in 2024 to reach 56.97 million USD by 2031, at a CAGR of 3.57% during the forecast period of 2025 through 2031.

Asia-Pacific market for B2B Mold Inhibitors is estimated to increase from 60.38 million USD in 2024 to reach 106.56 million USD by 2031, at a CAGR of 7.11% during the forecast period of 2025 through 2031.

The major global manufacturers of B2B Mold Inhibitors include Sanitized, Guangdong Dimei Biological Technology, Sinanen Zeomic, 3D Bio-chem, Thermaset, iHeir, Daiko Technical, Colloids, I'm Biotechnology, Guangzhou Good Nice Anti-Mold, etc. In 2024, the world's top five vendors accounted for approximately 48.32% of the revenue.

This report aims to provide a comprehensive presentation of the global market for B2B Mold Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B2B Mold Inhibitors.

The B2B Mold Inhibitors market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global B2B Mold Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the B2B Mold Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Sanitized
• Guangdong Dimei Biological Technology
• Sinanen Zeomic
• 3D Bio-chem
• Thermaset
• iHeir
• Daiko Technical
• Colloids
• I'm Biotechnology
• Guangzhou Good Nice Anti-Mold
• Suzhou Anmei Material Technology

Segment by Type

• Powder
• Coating
• Masterbatch

Segment by Application

• Plastics and Polymers
• Textile
• Building Material and Exterior Wall
• Housing Equipment
• Others

Production by Region

• North America
• Europe
• China
• Japan

Consumption by Region

• North America
• U.S.
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Rest of Europe
• Latin America, Middle East & Africa
• Mexico
• Brazil
• GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of B2B Mold Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of B2B Mold Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of B2B Mold Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 B2B Mold Inhibitors Market Overview

• 1.1 Product Definition
• 1.2 B2B Mold Inhibitors by Type
  • 1.2.1 Global B2B Mold Inhibitors Market Value Growth Rate Analysis by Type: 2024 VS 2031
  • 1.2.2 Powder
  • 1.2.3 Coating
  • 1.2.4 Masterbatch
• 1.3 B2B Mold Inhibitors by Application
  • 1.3.1 Global B2B Mold Inhibitors Market Value Growth Rate Analysis by Application: 2024 VS 2031
  • 1.3.2 Plastics and Polymers
  • 1.3.3 Textile
  • 1.3.4 Building Materials and Exterior Wall
  • 1.3.5 Housing Equipment
  • 1.3.6 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031)
  • 1.4.2 Global B2B Mold Inhibitors Production Capacity Estimates and Forecasts (2020-2031)
  • 1.4.3 Global B2B Mold Inhibitors Production Estimates and Forecasts (2020-2031)
  • 1.4.4 Global B2B Mold Inhibitors Market Average Price Estimates and Forecasts (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global B2B Mold Inhibitors Production Market Share by Manufacturers (2020-2025)
• 2.2 Global B2B Mold Inhibitors Production Value Market Share by Manufacturers (2020-2025)
• 2.3 Global Key Players of B2B Mold Inhibitors, Industry Ranking, 2023 VS 2024
• 2.4 Global B2B Mold Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global B2B Mold Inhibitors Average Price by Manufacturers (2020-2025)
• 2.6 Global Key Manufacturers of B2B Mold Inhibitors, Manufacturing Base Distribution and Headquarters
• 2.7 Global Key Manufacturers of B2B Mold Inhibitors, Product Offered and Application
• 2.8 Global Key Manufacturers of B2B Mold Inhibitors, Founding date
• 2.9 B2B Mold Inhibitors Market Competitive Situation and Trends
  • 2.9.1 B2B Mold Inhibitors Market Concentration Rate
  • 2.9.2 Global 5 and 10 Largest B2B Mold Inhibitors Players Market Share by Revenue

3 B2B Mold Inhibitors Production by Region

• 3.1 Global B2B Mold Inhibitors Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.2 Global B2B Mold Inhibitors Production Value by Region (2020-2031)
  • 3.2.1 Global B2B Mold Inhibitors Production Value Market Share by Region (2020-2025)
  • 3.2.2 Global Forecasted Production Value of B2B Mold Inhibitors by Region (2026-2031)
• 3.3 Global B2B Mold Inhibitors Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.4 Global B2B Mold Inhibitors Production by Region (2020-2031)
  • 3.4.1 Global B2B Mold Inhibitors Production Market Share by Region (2020-2025)
  • 3.4.2 Global Forecasted Production of B2B Mold Inhibitors by Region (2026-2031)
• 3.5 Global B2B Mold Inhibitors Market Price Analysis by Region (2020-2025)
• 3.6 Global B2B Mold Inhibitors Production and Value, Year-over-Year Growth
  • 3.6.1 North America B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031)
  • 3.6.2 Europe B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031)
  • 3.6.3 China B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031)
  • 3.6.4 Japan B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031)

4 B2B Mold Inhibitors Consumption by Region

• 4.1 Global B2B Mold Inhibitors Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 4.2 Global B2B Mold Inhibitors Consumption by Region (2020-2031)
  • 4.2.1 Global B2B Mold Inhibitors Consumption by Region (2020-2031)
  • 4.2.2 Global B2B Mold Inhibitors Forecasted Consumption by Region (2026-2031)
• 4.3 North America
  • 4.3.1 North America B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.3.2 North America B2B Mold Inhibitors Consumption by Country (2020-2031)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.4.2 Europe B2B Mold Inhibitors Consumption by Country (2020-2031)
  • 4.4.3 Germany
  • 4.4.4 France
  • 4.4.5 U.K.
  • 4.4.6 Italy
  • 4.4.7 Russia
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.5.2 Asia Pacific B2B Mold Inhibitors Consumption by Region (2020-2031)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 South Korea
  • 4.5.6 Southeast Asia
  • 4.5.7 India
  • 4.5.8 Australia
• 4.6 Latin America
  • 4.6.1 Latin America B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.6.2 Latin America B2B Mold Inhibitors Consumption by Country (2020-2031)
  • 4.6.3 Mexico
  • 4.6.4 Brazil
• 4.7 Middle East and Africa
  • 4.7.1 Middle East and Africa B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.7.2 Middle East and Africa B2B Mold Inhibitors Consumption by Country (2020-2031)
  • 4.7.3 Saudi Arabia
  • 4.7.4 UAE
  • 4.7.5 Egypt
  • 4.7.6 South Africa

5 Segment by Type

• 5.1 Global B2B Mold Inhibitors Production by Type (2020-2031)
  • 5.1.1 Global B2B Mold Inhibitors Production by Type (2020-2025)
  • 5.1.2 Global B2B Mold Inhibitors Production by Type (2026-2031)
  • 5.1.3 Global B2B Mold Inhibitors Production Market Share by Type (2020-2031)
• 5.2 Global B2B Mold Inhibitors Production Value by Type (2020-2031)
  • 5.2.1 Global B2B Mold Inhibitors Production Value by Type (2020-2025)
  • 5.2.2 Global B2B Mold Inhibitors Production Value by Type (2026-2031)
  • 5.2.3 Global B2B Mold Inhibitors Production Value Market Share by Type (2020-2031)
• 5.3 Global B2B Mold Inhibitors Price by Type (2020-2031)

6 Segment by Application

• 6.1 Global B2B Mold Inhibitors Production by Application (2020-2031)
  • 6.1.1 Global B2B Mold Inhibitors Production by Application (2020-2025)
  • 6.1.2 Global B2B Mold Inhibitors Production by Application (2026-2031)
  • 6.1.3 Global B2B Mold Inhibitors Production Market Share by Application (2020-2031)
• 6.2 Global B2B Mold Inhibitors Production Value by Application (2020-2031)
  • 6.2.1 Global B2B Mold Inhibitors Production Value by Application (2020-2025)
  • 6.2.2 Global B2B Mold Inhibitors Production Value by Application (2026-2031)
  • 6.2.3 Global B2B Mold Inhibitors Production Value Market Share by Application (2020-2031)
• 6.3 Global B2B Mold Inhibitors Price by Application (2020-2031)

7 Key Companies Profiled

• 7.1 Sanitized
  • 7.1.1 Sanitized B2B Mold Inhibitors Company Information
  • 7.1.2 Sanitized B2B Mold Inhibitors Product Portfolio
  • 7.1.3 Sanitized B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.1.4 Sanitized Main Business and Markets Served
  • 7.1.5 Sanitized Recent Developments/Updates
• 7.2 Guangdong Dimei Biological Technology
  • 7.2.1 Guangdong Dimei Biological Technology B2B Mold Inhibitors Company Information
  • 7.2.2 Guangdong Dimei Biological Technology B2B Mold Inhibitors Product Portfolio
  • 7.2.3 Guangdong Dimei Biological Technology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.2.4 Guangdong Dimei Biological Technology Main Business and Markets Served
• 7.3 Sinanen Zeomic
  • 7.3.1 Sinanen Zeomic B2B Mold Inhibitors Company Information
  • 7.3.2 Sinanen Zeomic B2B Mold Inhibitors Product Portfolio
  • 7.3.3 Sinanen Zeomic B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.3.4 Sinanen Zeomic Main Business and Markets Served
  • 7.3.5 Sinanen Zeomic Recent Developments/Updates
• 7.4 3D Bio-chem
  • 7.4.1 3D Bio-chem B2B Mold Inhibitors Company Information
  • 7.4.2 3D Bio-chem B2B Mold Inhibitors Product Portfolio
  • 7.4.3 3D Bio-chem B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.4.4 3D Bio-chem Main Business and Markets Served
• 7.5 Thermaset
  • 7.5.1 Thermaset B2B Mold Inhibitors Company Information
  • 7.5.2 Thermaset B2B Mold Inhibitors Product Portfolio
  • 7.5.3 Thermaset B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.5.4 Thermaset Main Business and Markets Served
• 7.6 iHeir
  • 7.6.1 iHeir B2B Mold Inhibitors Company Information
  • 7.6.2 iHeir B2B Mold Inhibitors Product Portfolio
  • 7.6.3 iHeir B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.6.4 iHeir Main Business and Markets Served
• 7.7 Daiko Technical
  • 7.7.1 Daiko Technical B2B Mold Inhibitors Company Information
  • 7.7.2 Daiko Technical B2B Mold Inhibitors Product Portfolio
  • 7.7.3 Daiko Technical B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.7.4 Daiko Technical Main Business and Markets Served
• 7.8 Colloids
  • 7.8.1 Colloids B2B Mold Inhibitors Company Information
  • 7.8.2 Colloids B2B Mold Inhibitors Product Portfolio
  • 7.8.3 Colloids B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.8.4 Colloids Main Business and Markets Served
• 7.9 I'm Biotechnology
  • 7.9.1 I'm Biotechnology B2B Mold Inhibitors Company Information
  • 7.9.2 I'm Biotechnology B2B Mold Inhibitors Product Portfolio
  • 7.9.3 I'm Biotechnology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.9.4 I'm Biotechnology Main Business and Markets Served
• 7.10 Guangzhou Good Nice Anti-Mold
  • 7.10.1 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Company Information
  • 7.10.2 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Product Portfolio
  • 7.10.3 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.10.4 Guangzhou Good Nice Anti-Mold Main Business and Markets Served
• 7.11 Suzhou Anmei Material Technology
  • 7.11.1 Suzhou Anmei Material Technology B2B Mold Inhibitors Company Information
  • 7.11.2 Suzhou Anmei Material Technology B2B Mold Inhibitors Product Portfolio
  • 7.11.3 Suzhou Anmei Material Technology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025)
  • 7.11.4 Suzhou Anmei Material Technology Main Business and Markets Served

8 Industry Chain and Sales Channels Analysis

• 8.1 B2B Mold Inhibitors Industry Chain Analysis
• 8.2 B2B Mold Inhibitors Raw Material Supply Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 B2B Mold Inhibitors Production Mode & Process Analysis
• 8.4 B2B Mold Inhibitors Sales and Marketing
  • 8.4.1 B2B Mold Inhibitors Sales Channels
  • 8.4.2 B2B Mold Inhibitors Distributors
• 8.5 B2B Mold Inhibitors Customer Analysis

9 B2B Mold Inhibitors Market Dynamics

• 9.1 B2B Mold Inhibitors Industry Trends
• 9.2 B2B Mold Inhibitors Market Drivers
• 9.3 B2B Mold Inhibitors Market Challenges
• 9.4 B2B Mold Inhibitors Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer 134